Your browser doesn't support javascript.
loading
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
Harrington, Brittney S; Kamdar, Rahul; Ning, Franklin; Korrapati, Soumya; Caminear, Michael W; Hernandez, Lidia F; Butcher, Donna; Edmondson, Elijah F; Traficante, Nadia; Hendley, Joy; Gough, Madeline; Rogers, Rebecca; Lourie, Rohan; Shetty, Jyoti; Tran, Bao; Elloumi, Fathi; Abdelmaksoud, Abdalla; Nag, Madhu Lal; Mazan-Mamczarz, Krystyna; House, Carrie D; Hooper, John D; Annunziata, Christina M.
Afiliação
  • Harrington BS; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Kamdar R; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Ning F; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Korrapati S; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Caminear MW; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Hernandez LF; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Butcher D; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, NCI, Frederick, MD, 21702, USA.
  • Edmondson EF; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, NCI, Frederick, MD, 21702, USA.
  • Traficante N; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Hendley J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
  • Gough M; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
  • Lourie R; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD, 4101, Australia.
  • Shetty J; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD, 4102, Australia.
  • Tran B; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD, 4101, Australia.
  • Elloumi F; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD, 4101, Australia.
  • Abdelmaksoud A; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD, 4102, Australia.
  • Nag ML; CCR Sequencing Facility, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 21701, USA.
  • Mazan-Mamczarz K; CCR Sequencing Facility, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 21701, USA.
  • House CD; Collaborative Bioinformatics Resource (CCBR), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.
  • Hooper JD; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Annunziata CM; Collaborative Bioinformatics Resource (CCBR), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.
J Exp Clin Cancer Res ; 42(1): 270, 2023 Oct 19.
Article em En | MEDLINE | ID: mdl-37858159
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Uridina Difosfato Glucose Desidrogenase / Microambiente Tumoral / Carcinoma Epitelial do Ovário Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Uridina Difosfato Glucose Desidrogenase / Microambiente Tumoral / Carcinoma Epitelial do Ovário Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article